Andrew D Cherniack

age ~61

from Shrewsbury, MA

Get Report

Also known as:

Andy D Cherniack
Andrew D Cherniak
Andre Cherniack

Phone and address:: 11 Ridge Rd, Shrewsbury, MA 01545
5088458924

Connected to:

Andrew Cherniack Phones & Addresses

11 Ridge Rd, Shrewsbury, MA 01545 • 5088458924
22 Wigwam Hill Dr, Worcester, MA 01605 • 5087562686
Columbus, OH

Work

Company:

Dana-farber cancer institute
2015
Position:

Group leader

Education

Degree:

Doctorates, Doctor of Philosophy
School / High School:

The Ohio State University
Specialities:

Genetics

Skills

Molecular Biology • Genomics • Genetics • Cancer • Assay Development • Biomarkers • Cell Biology • Computational Biology • Bioinformatics • Biotechnology • Biochemistry • Drug Discovery • Clinical Development • Cancer Genomics • Gene Expression Profiling • Life Sciences • R • Sequence Analysis • Microarray Analysis • Management

Industries

Biotechnology

Us Patents

Rip140 Regulation Of Diabetes
view source
US Patent:

8093223, Jan 10, 2012
Filed:

Oct 8, 2009
Appl. No.:

12/575981
Inventors:

Michael P. Czech - Westborough MA, US
Aimee Powelka - Framingham MA, US
Adilson L. Guilherme - Shrewsbury MA, US
Andrew D. Cherniack - Shrewsbury MA, US
Assignee:

University of Massachusetts - Boston MA
International Classification:

A61K 48/00
US Classification:

514 44, 536 245, 536 241, 536 2431
Abstract:

Inhibition of RIP140 increases glucose transport. Compounds that inhibit RIP140 expression or activity are useful for treating disorders associated with aberrant glucose transport (e. g. , diabetes), treating obesity, increasing metabolism (e. g. , fatty acid metabolism), and increasing brown fat.

Rip140 Regulation Of Glucose Transport
view source
US Patent:

8519118, Aug 27, 2013
Filed:

Jan 6, 2012
Appl. No.:

13/345390
Inventors:

Michael P. Czech - Westborough MA, US
Aimee Powelka - Framingham MA, US
Adilson L. Guilherme - Shrewsbury MA, US
Andrew D. Cherniack - Worcester MA, US
Assignee:

University of Massachusetts - Boston MA
International Classification:

C07H 21/04
US Classification:

536 245, 536 241, 536 2431, 514 44
Abstract:

Inhibition of RIP140 increases glucose transport. Compounds that inhibit RIP140 expression or activity are useful for treating disorders associated with aberrant glucose transport (e. g. , diabetes), treating obesity, increasing metabolism (e. g. , fatty acid metabolism), and increasing brown fat.

Glucose Transport-Related Genes And Uses Thereof
view source
US Patent:

20020155472, Oct 24, 2002
Filed:

Oct 22, 2001
Appl. No.:

10/021162
Inventors:

Michael Czech - Westborough MA, US
Andrew Cherniack - Worcester MA, US
Adilson Guilherme - Shrewsbury MA, US
International Classification:

C12Q001/68
C12M001/34
US Classification:

435/006000, 435/287200
Abstract:

Nucleotide sequences and amino acid sequences from nucleic acids and proteins involved in glucose transport are disclosed. The sequences are useful for producing DNA arrays that can be used for the diagnosis of, predictive testing for, and development of treatments for disorders involving glucose transport such as type II diabetes.

Glucose Transport-Related Genes And Uses Thereof
view source
US Patent:

20050059007, Mar 17, 2005
Filed:

Jun 30, 2003
Appl. No.:

10/610018
Inventors:

Michael Czech - Westborough MA, US
Andrew Cherniack - Worcester MA, US
Adilson Guilherme - Shrewsbury MA, US
International Classification:

C12Q001/68
C12M001/34
US Classification:

435006000, 435287200
Abstract:

Nucleotide sequences and amino acid sequences from nucleic acids and proteins involved in glucose transport are disclosed. The sequences are useful for producing DNA arrays that can be used for the diagnosis of, predictive testing for, and development of treatments for disorders involving glucose transport such as type II diabetes.

Rip140 Regulation Of Glucose Transport
view source
US Patent:

20050261223, Nov 24, 2005
Filed:

Mar 7, 2005
Appl. No.:

11/075646
Inventors:

Michael Czech - Westborough MA, US
Aimee Powelka - Framingham MA, US
Adilson Guilherme - Shrewsbury MA, US
Andrew Cherniack - Shrewsbury MA, US
International Classification:

A61K048/00
A61K038/17
A61K039/395
US Classification:

514044000, 514012000, 424143100
Abstract:

Inhibition of RIP140 increases glucose transport. Compounds that inhibit RIP140 expression or activity are useful for treating disorders associated with aberrant glucose transport (e.g., diabetes), treating obesity, increasing metabolism (e.g., fatty acid metabolism), and increasing brown fat.

Resumes

Group Leader

view source

Location:

415 Main St, Cambridge, MA 02142

Industry:

Biotechnology

Work:

Dana-Farber Cancer Institute
Group Leader
Broad Institute
Group Leader
Broad Institute 2010 - 2014
Research Scientist Ii
Abbvie 2001 - 2010
Senior Scientist Ii and Senior Scientist Iii
Umass Medical School 1992 - 2001
Post Doc and Research Assistant Professor

Education:

The Ohio State University
Doctorates, Doctor of Philosophy, Genetics University of Pennsylvania
Bachelors, Bachelor of Arts, Biology

Skills:

Molecular Biology
Genomics
Genetics
Cancer
Assay Development
Biomarkers
Cell Biology
Computational Biology
Bioinformatics
Biotechnology
Biochemistry
Drug Discovery
Clinical Development
Cancer Genomics
Gene Expression Profiling
Life Sciences
R
Sequence Analysis
Microarray Analysis
Management